A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis
Status: Not yet recruiting
Phase of Trial: Phase II/III
Latest Information Update: 12 Dec 2019
Price : $35 *
At a glance
- Drugs Vancomycin (Primary)
- Indications Primary sclerosing cholangitis
- Focus Therapeutic Use
- 09 Dec 2019 Status changed from recruiting to not yet recruiting.
- 10 Dec 2018 Planned number of patients changed from 103 to 102.
- 25 Oct 2018 New trial record